UTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Minerva Surgical's Total Assets for the quarter that ended in Sep. 2023 was $72.79 Mil.
During the past 12 months, Minerva Surgical's average Total Assets Growth Rate was -10.20% per year. During the past 3 years, the average Total Assets Growth Rate was 46.80% per year.
During the past 4 years, Minerva Surgical's highest 3-Year average Total Assets Growth Rate was 46.80%. The lowest was 46.80%. And the median was 46.80%.
Total Assets is connected with ROA %. Minerva Surgical's annualized ROA % for the quarter that ended in Sep. 2023 was -37.77%. Total Assets is also linked to Revenue through Asset Turnover. Minerva Surgical's Asset Turnover for the quarter that ended in Sep. 2023 was 0.16.
The historical data trend for Minerva Surgical's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Total Assets | 46.68 | 92.05 | 115.09 | 68.90 |
Minerva Surgical Quarterly Data | |||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Total Assets | Get a 7-Day Free Trial | 83.80 | 68.90 | 85.17 | 79.30 | 72.79 |
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Minerva Surgical's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as
Total Assets | = | Total Equity (A: Dec. 2022 ) | + | Total Liabilities (A: Dec. 2022 ) |
= | 17.181 | + | 51.719 | |
= | 68.90 |
Minerva Surgical's Total Assets for the quarter that ended in Sep. 2023 is calculated as
Total Assets | = | Total Equity (Q: Sep. 2023 ) | + | Total Liabilities (Q: Sep. 2023 ) |
= | 20.255 | + | 52.53 | |
= | 72.79 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical (OTCPK:UTRS) Total Assets Explanation
Total Assets is connected with ROA %.
Minerva Surgical's annualized ROA % for the quarter that ended in Sep. 2023 is
ROA % | = | Net Income (Q: Sep. 2023 ) | / | ( (Total Assets (Q: Jun. 2023 ) | + | Total Assets (Q: Sep. 2023 )) | / count ) |
= | -28.724 | / | ( (79.303 | + | 72.785) | / 2 ) | |
= | -28.724 | / | 76.044 | ||||
= | -37.77 % |
Note: The Net Income data used here is four times the quarterly (Sep. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Minerva Surgical's Asset Turnover for the quarter that ended in Sep. 2023 is
Asset Turnover | ||||||
= | Revenue (Q: Sep. 2023 ) | / | ( (Total Assets (Q: Jun. 2023 ) | + | Total Assets (Q: Sep. 2023 )) | / count ) |
= | 11.965 | / | ( (79.303 | + | 72.785) | / 2 ) |
= | 11.965 | / | 76.044 | |||
= | 0.16 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Thank you for viewing the detailed overview of Minerva Surgical's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Cohen | director | C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131 |
Accelmed Partners Ii L.p. | 10 percent owner | 2875 NE 191ST, SUITE 500, AVENTURA FL 33180 |
New Enterprise Associates 13 Lp | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
Uri Geiger | director, 10 percent owner | 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815 |
Todd Usen | director, officer: Chief Executive Officer | C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054 |
Derrick Sung | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103 |
David M Clapper | director, officer: President and CEO | 3003 TASMAN DRIVE, SANTA CLARA CA 95054 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
Jaffe Ross A Md | director | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Evgueni V. Skalnyi | officer: VP Medical Affairs | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Dominique J. Filloux | officer: COO | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Joel R Jung | officer: CFO | 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502 |
Niquette L. Hunt | director | SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081 |
Jill Anderson | director | 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095 |
Nea Partners 13, Limited Partnership | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
From GuruFocus
By PurpleRose PurpleRose • 07-28-2022
By Tiesvg Tiesvg • 12-27-2022
By sperokesalga sperokesalga • 04-18-2023
By Value_Insider Value_Insider • 11-07-2022
By Tiesvg Tiesvg • 12-28-2022
By GlobeNewswire GlobeNewswire • 12-27-2022
By sperokesalga sperokesalga • 03-21-2023
By GuruFocus Research GuruFocus Editor • 05-11-2022
By PurpleRose PurpleRose • 08-03-2022
By GuruFocusNews GuruFocusNews • 06-19-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.